Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PARANOID! TIRED OF TALKING TO YOURSELF? LET'S TALK(TTP) -- Ignore unavailable to you. Want to Upgrade?

To: Scott H. Davis who wrote (51)	4/26/1998 9:01:00 AM
From: Arthur Radley	Respond to of 626

Morning Scott, TTNP is an interesting company with some potential for price appreciation in the future.(IMO) Next news will come from the second phase trial for their cancer indications. To the best of my knowledge, their work is not with melanoma. Instead, it is with colon, small cell lung, and breast cancers. As for Sturza, as of his 4/2/98 model portfolio update, ISIP is not one of the stocks that he has (long or short) in his list of holdings. His shorts are: apht, nvx, org, lipo He has probably covered his (org) position since he has had his head delivered on a silver platter with this one, as he shorted it at $11.00. After you get your information from TTNP, I would appreciate your reaction to their information.. The CFO is a good person to talk with at TTNP. He is a willing talker for anyone wanting information about the company. P.S. Since it appears that you like medical stocks, you might take a look at PolyMedica(pm). We have an active group here on SI that follows the stock.